{"title":"虚拟现实对精神分裂症患者负面症状和生活质量的影响:一项荟萃分析。","authors":"Shiqiu Liu, Shuaibo Tang, Youguo Tan, Bo Xiang","doi":"10.1177/07067437251372186","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Schizophrenia brings about diverse challenges to patients, their families and society. It is up to the healthcare system to effectively resolve these concerns and benefit all involved parties. With the emerging development and adaptation of virtual reality (VR), this may offer a new direction and potential for treating people with schizophrenia. Our goal was to employ meta-analysis to evaluate the influence of VR on the clinical outcomes and quality of life in people with schizophrenia.</p><p><strong>Methods: </strong>We performed an extensive screening of randomized controlled trials (RCTs) examining the effect of VR on the clinical outcomes in people with schizophrenia. Our search included the scientific databases PubMed, Embase, Web of Science and the Cochrane Library, and included RCTs from the date of database establishment till 1 June 2023 and we followed a strict study of inclusion and exclusion criteria. The meta-analysis was conducted in RevMan 5.4.</p><p><strong>Results: </strong>We selected 963 patients from 10 RCTs. Relative to other forms of interventions, VR therapy considerably alleviated overall clinical (SMD = -4.33, 95% CI = [-6.92, -1.74], <i>P</i> = 0.001) and negative symptomology (SMD = -1.38, 95% CI = [-2.46, -0.30], <i>P</i> = 0.01) among in people with schizophrenia. In contrast, no significant improvements were observed in positive symptoms or quality of life among these patients. Further subgroup analyses of the results indicated that there were differences in the improvement of negative symptoms among patients across the different interventions (<i>P</i> = 0.01).</p><p><strong>Conclusions: </strong>Based on our meta-analysis, VR-based treatment regimen significantly improves overall and negative symptoms in people with schizophrenia. Further exploration is warranted to elucidate the influence of VR on patient positive symptoms and quality of life.</p>","PeriodicalId":55283,"journal":{"name":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","volume":" ","pages":"7067437251372186"},"PeriodicalIF":3.8000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405201/pdf/","citationCount":"0","resultStr":"{\"title\":\"Influence of Virtual Reality on Negative Symptoms and Quality of Life of Patients With Schizophrenia: A Meta-Analysis: Influence de la réalité virtuelle sur les symptômes négatifs et la qualité de vie des patients atteints de schizophrénie : une méta-analyse.\",\"authors\":\"Shiqiu Liu, Shuaibo Tang, Youguo Tan, Bo Xiang\",\"doi\":\"10.1177/07067437251372186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Schizophrenia brings about diverse challenges to patients, their families and society. It is up to the healthcare system to effectively resolve these concerns and benefit all involved parties. With the emerging development and adaptation of virtual reality (VR), this may offer a new direction and potential for treating people with schizophrenia. Our goal was to employ meta-analysis to evaluate the influence of VR on the clinical outcomes and quality of life in people with schizophrenia.</p><p><strong>Methods: </strong>We performed an extensive screening of randomized controlled trials (RCTs) examining the effect of VR on the clinical outcomes in people with schizophrenia. Our search included the scientific databases PubMed, Embase, Web of Science and the Cochrane Library, and included RCTs from the date of database establishment till 1 June 2023 and we followed a strict study of inclusion and exclusion criteria. The meta-analysis was conducted in RevMan 5.4.</p><p><strong>Results: </strong>We selected 963 patients from 10 RCTs. Relative to other forms of interventions, VR therapy considerably alleviated overall clinical (SMD = -4.33, 95% CI = [-6.92, -1.74], <i>P</i> = 0.001) and negative symptomology (SMD = -1.38, 95% CI = [-2.46, -0.30], <i>P</i> = 0.01) among in people with schizophrenia. In contrast, no significant improvements were observed in positive symptoms or quality of life among these patients. Further subgroup analyses of the results indicated that there were differences in the improvement of negative symptoms among patients across the different interventions (<i>P</i> = 0.01).</p><p><strong>Conclusions: </strong>Based on our meta-analysis, VR-based treatment regimen significantly improves overall and negative symptoms in people with schizophrenia. Further exploration is warranted to elucidate the influence of VR on patient positive symptoms and quality of life.</p>\",\"PeriodicalId\":55283,\"journal\":{\"name\":\"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie\",\"volume\":\" \",\"pages\":\"7067437251372186\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405201/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/07067437251372186\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/07067437251372186","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
背景:精神分裂症给患者、家庭和社会带来了多方面的挑战。这取决于医疗系统有效地解决这些问题,并使所有相关方受益。随着虚拟现实(VR)技术的发展和适应,这可能为精神分裂症的治疗提供新的方向和潜力。我们的目标是采用荟萃分析来评估VR对精神分裂症患者临床结果和生活质量的影响。方法:我们进行了广泛的随机对照试验(rct)筛选,以检查VR对精神分裂症患者临床结局的影响。我们的检索包括科学数据库PubMed、Embase、Web of Science和Cochrane Library,并纳入了从数据库建立之日起至2023年6月1日的随机对照试验,我们遵循了严格的纳入和排除标准。meta分析采用RevMan 5.4进行。结果:我们从10项随机对照试验中选择了963例患者。相对于其他形式的干预,VR治疗显著缓解了精神分裂症患者的整体临床症状(SMD = -4.33, 95% CI = [-6.92, -1.74], P = 0.001)和阴性症状(SMD = -1.38, 95% CI = [-2.46, -0.30], P = 0.01)。相比之下,这些患者的阳性症状或生活质量没有明显改善。进一步的亚组分析结果表明,在不同干预措施的患者中,阴性症状的改善存在差异(P = 0.01)。结论:根据我们的荟萃分析,基于vr的治疗方案可显著改善精神分裂症患者的整体症状和阴性症状。VR对患者阳性症状和生活质量的影响有待进一步探讨。
Influence of Virtual Reality on Negative Symptoms and Quality of Life of Patients With Schizophrenia: A Meta-Analysis: Influence de la réalité virtuelle sur les symptômes négatifs et la qualité de vie des patients atteints de schizophrénie : une méta-analyse.
Background: Schizophrenia brings about diverse challenges to patients, their families and society. It is up to the healthcare system to effectively resolve these concerns and benefit all involved parties. With the emerging development and adaptation of virtual reality (VR), this may offer a new direction and potential for treating people with schizophrenia. Our goal was to employ meta-analysis to evaluate the influence of VR on the clinical outcomes and quality of life in people with schizophrenia.
Methods: We performed an extensive screening of randomized controlled trials (RCTs) examining the effect of VR on the clinical outcomes in people with schizophrenia. Our search included the scientific databases PubMed, Embase, Web of Science and the Cochrane Library, and included RCTs from the date of database establishment till 1 June 2023 and we followed a strict study of inclusion and exclusion criteria. The meta-analysis was conducted in RevMan 5.4.
Results: We selected 963 patients from 10 RCTs. Relative to other forms of interventions, VR therapy considerably alleviated overall clinical (SMD = -4.33, 95% CI = [-6.92, -1.74], P = 0.001) and negative symptomology (SMD = -1.38, 95% CI = [-2.46, -0.30], P = 0.01) among in people with schizophrenia. In contrast, no significant improvements were observed in positive symptoms or quality of life among these patients. Further subgroup analyses of the results indicated that there were differences in the improvement of negative symptoms among patients across the different interventions (P = 0.01).
Conclusions: Based on our meta-analysis, VR-based treatment regimen significantly improves overall and negative symptoms in people with schizophrenia. Further exploration is warranted to elucidate the influence of VR on patient positive symptoms and quality of life.
期刊介绍:
Established in 1956, The Canadian Journal of Psychiatry (The CJP) has been keeping psychiatrists up-to-date on the latest research for nearly 60 years. The CJP provides a forum for psychiatry and mental health professionals to share their findings with researchers and clinicians. The CJP includes peer-reviewed scientific articles analyzing ongoing developments in Canadian and international psychiatry.